Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.
Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.
复制标题
抑制脂肪分解可改善阻塞性睡眠呼吸暂停小鼠模型的糖尿病表型。
DOI:
10.1165/rcmb.2015-0315oc
复制
发表时间:
2016
影响因子:
6.4
通讯作者:
Polak,Jan
中科院分区:
文献类型:
--
作者:
Weiszenstein,Martin;Shimoda,LarissaA;Koc,Michal;Seda,Ondrej;Polak,Jan
Obstructive sleep apnea (OSA) is associated with insulin resistance, glucose intolerance, and type 2 diabetes. Causal mechanisms mediating this association are not well defined; however, augmented lipolysis in adipose might be involved. Here, we investigated the effect of acipimox treatment (lipolysis inhibitor) on glucose tolerance and insulin sensitivity in mice exposed to intermittent hypoxia (IH). C57BL6/J mice were exposed for 14 days to IH or control conditions. IH was created by decreasing the fraction of inspired oxygen from 20.9 to 6.5%, 60 times/h. Control exposure was air (fraction of inspired oxygen, 20.9%) delivered at an identical flow rate. Acipimox was provided in drinking water (0.5 g/ml) during exposures. After exposures, intraperitoneal insulin (0.5 IU/kg) and glucose (1 g/kg) tolerance tests were performed, and primary adipocytes were isolated for lipolysis experiments. IH elevated fasting glucose by 51% and worsened glucose tolerance and insulin sensitivity by 33 and 102%, respectively. In parallel, IH increased spontaneous lipolysis by 264%, and reduced epididymal fat mass by 15% and adipocyte size by 8%. Acipimox treatment prevented IH-induced lipolysis and increased epididymal fat mass and adipocyte size by 19 and 10%, respectively. Acipimox fully prevented IH-induced impairments in fasting glycemia, glucose tolerance, and insulin sensitivity. For all reported results,Pless than 0.05 was considered significant. Augmented lipolysis contributes to insulin resistance and glucose intolerance observed in mice exposed to IH. Acipimox treatment ameliorated the metabolic consequences of IH and might represent a novel treatment option for patients with obstructive sleep apnea.
登录
查看更多内容
DOI:
--
发表时间:
1968
期刊:
Biochimica et Biophysica Acta
影响因子:
--
作者:
R. Cowgill
通讯作者:
R. Cowgill
DOI:
--
发表时间:
1986
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Wright,SF;Berkowitz,P;Deerfield2nd,DW;Byrd,PA;Olson,DL;Larson,RS;Hinn,GC;Koehler,KA;Pedersen,LG;Hiskey,RG
通讯作者:
Hiskey,RG
影响因子:
4.8
作者:
G. Nelsestuen
通讯作者:
G. Nelsestuen
DOI:
--
发表时间:
1975
期刊:
影响因子:
--
作者:
G. Nelsestuen;M. Broderius;T. Zytkovicz;J. Howard
通讯作者:
J. Howard
影响因子:
4.8
作者:
C. Heldebrant;K. Mann
通讯作者:
K. Mann